Evolus, Inc. [EOLS] is following downward trend in the market concluded with the last trading session. The shares of the Healthcare sector company has a current value of $19.32 after EOLS shares went down by -2.77% during the last trading session. One of the reasons why Healthcare stocks may go bearish is decreased momentum in the press.

Evolus, Inc. [NASDAQ:EOLS]: Analyst Rating and Earnings

Experts stock market traders frequently make a point to check what top Wall Street analysts say regarding a potential buy. Regarding Evolus, Inc. [EOLS] currently, the latest Wall Street ratings we can see is from the fiscal quarter that’s going to end in December. On average, stock market experts give EOLS an Outperform rating. Its stock price has been found in the range of 10.22 to 30.25. This is compared to its latest closing price of $19.87.

Wall Street analysts provide their ratings on a scale of 1 to 5, and the current average score for Evolus, Inc. [EOLS] is sitting at 2.44. This is compared to 1 month ago, when its average rating was 2.38.

Stay on the lookout for the next publication of this organization’s financial results for the quarter, which will be made public on Thu 1 Aug (In 13 Days).

Fundamental Analysis of Evolus, Inc. [EOLS]

Turning to investigate this organization’s capital structure, Evolus, Inc. [EOLS] has generated a Total Debt to Total Equity ratio of 20.03. Similarly, its Total Debt to Total Capital is 16.69, while its Total Debt to Total Assets stands at 9.84. Looking toward the future, this publicly-traded company’s Long-Term Debt to Equity is 20.03, and its Long-Term Debt to Total Capital is 16.69. This company is not leveraging its assets to take on debt, which stunts its growth and limits the ROI for investors.

What about valuation? This company’s Enterprise Value to EBITDA is -9.91. Total Debt to Enterprise Value stands at 0.08. Evolus, Inc. [EOLS] has a Price to Book Ratio of 3.85.

This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 17.88 and its Current Ratio is 17.88. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.

Evolus, Inc. [EOLS] has 27.42M shares outstanding, amounting to a total market cap of $544.84M. Its stock price has been found in the range of 10.22 to 30.25. At its current price, it has moved down by -36.13% from its 52-week high, and it has moved up 89.01% from its 52-week low.

This stock’s Relative Strength Index (RSI) is at 71.72. This RSI suggests that Evolus, Inc. is currently Overbought.

Conclusion: Is Evolus, Inc. [EOLS] a Reliable Buy?

Evolus, Inc. [EOLS] stock is presenting a less attractive investment opportunity when compared to similarly-sized corporations in the same industry. The price performance of these shares has not shown much promise, and the financial results that this company has recently delivered present a highly risky investment.